Quasar Medical Completes Acquisition of Nordson Medical's Galway and Tecate Facilities, Boosting Global CDMO Platform

Reuters
Sep 02
Quasar Medical Completes Acquisition of Nordson Medical's Galway and Tecate Facilities, Boosting Global CDMO Platform

Quasar Medical has completed the acquisition of Nordson Corporation's design and development contract manufacturing businesses located in Galway, Ireland, and Tecate, Mexico. This strategic move strengthens Quasar's global CDMO platform by expanding their capabilities in manufacturing interventional and minimally invasive medical devices. The acquisition enhances Quasar's ability to offer advanced product development, rapid prototyping, scalable manufacturing, and comprehensive testing capabilities. With this expansion, Quasar aims to accelerate time-to-market for customers and provide high-value solutions through vertical integration and operational excellence. The company will work closely with Nordson to ensure a seamless transition for all stakeholders involved.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nordson Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: CG62383) on September 02, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10